Welcome to the Utah Chapter of the American College of Cardiology
|
Ed Miner, MD, FACC Utah, Chapter President ACC Governor, Utah |
Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- CMS Releases Final 2027 Medicare Physician Fee Schedule and Hospital OPPS RulesThe Centers for Medicare and Medicaid Services (CMS) has released the final 2027 Medicare Physician Fee Schedule (PFS) and the Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System rules. Read on for early quick takes from both rules.
- Eagle’s Eye View: Underdiagnosis of AFib in Black Adults; Echocardiographic Evaluation; CAC Scores in Young Adults; Add-On Treatments For Resistant HypertensionIn this week’s View, Dr. Eagle looks at how black adults in disadvantaged neighborhoods are less likely to be diagnosed with atrial fibrillation (AFib).
- Safety and Efficacy of ProtEmbo Device; TAVR vs. SAVR in Patients with Symptomatic Severe AR at 1 YearThe ProtEmbo Cerebral Protection System met its primary safety endpoint but failed to meet its primary efficacy endpoint, adding to uncertainty regarding the routine use of cerebral embolic protection (CEP) in TAVR, according to findings from the PROTEMBO IDE trial presented on the final day of TCT 2026.
- EPIC17-VERONICA: Can Platelet Function Testing Guide P2Y12i Deescalation?In patients deemed to have very low platelet reactivity, switching from more potent P2Y12 inhibitors to clopidogrel did not improve outcomes at one year, according to findings from the EPIC17-VERONICA trial presented at TCT 2026.
- DUOTAP: Routine Postdilation May Optimize THV Geometry, HemodynamicsRoutine postdilation with a balloon-expandable transcatheter heart valve (THV) optimized THV geometry and improved hemodynamic performance, without increasing procedure-related adverse events in patients with severe aortic stenosis (AS), according to results from the DUOTAP trial presented at TCT 2026 and simultaneously published in JAMA Cardiology.